← Eichor
Study identifier: NCT05695963 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ecological Momentary Assessment in Patients With Restless Legs Syndrome

Condition: Restless Legs Syndrome  ·  Sponsor: University Hospital, Bordeaux

PhaseNA
Planned participants62
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The Restless Legs Syndrome (RLS) is a sensorimotor disorder better characterized by an urge to move the legs at rest. Although treatments are available, many patients experience periods of symptoms relief and exacerbation. Whether this is due to the natural history of the disease or to health-related behaviors of daily life is presently unknown. The primary objective is to examine the feasibility of mobile technology to assess RLS symptoms severity fluctuations in daily life by collecting real-time data. The secondary objectives will be to examine the validity of this technic in the context of RLS and to use these real-time data to identify daily life risk factors for symptom onset or aggravation.

This description comes directly from the study's public registry record.

Talk to the study team

Imad Marc Antoine GHORAYEB, MD, PhD  ·  (0)5.56.79.55.13  ·  marc-antoine.ghorayeb@chu-bordeaux.fr

Olivier BRANCHARD  ·  (0)5.57.82.06.97  ·  olivier.branchard@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de Bordeaux - Neurophysiologie Clinique de l'Enfant et de l'AdulteBordeaux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05695963